| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Microbiology | 68 | 148 | 174 | 28 |
| Medicine | 732 | 137 | 156 | 28 |
The aim of Infectious Diseases and Therapy is to expand the discussion of research in Internal medicine, Intensive care medicine, Antibiotics, Disease and Vaccination. While Internal medicine is the focus of Infectious Diseases and Therapy, it also provided insights into the studies of Gastroenterology and Bacteremia. It encompasses Antibiotics studies in the context of Microbiology as a whole.
Vancomycin and Staphylococcus aureus are some topics wherein Microbiology research discussed in Infectious Diseases and Therapy have an impact. Daptomycin is a major topic of Vancomycin research. The Staphylococcus aureus works, particularly on Methicillin-resistant Staphylococcus aureus are tackled in the journal.
The concepts on Vaccination presented in the journal can also apply to other research fields, including Pediatrics and Environmental health. Topics in Pediatrics were tackled in line with various other fields like Palivizumab and Epidemiology. The research on Adverse effect featured in the journal combines topics in other fields like Randomized controlled trial, Clinical trial and Discontinuation.
The most cited articles primarily focus on research topics in Intensive care medicine, Microbiology, Antibiotics, Pediatrics and Antimicrobial. While work presented in the most cited publications provide substantial information on Antibiotics, it also covers topics in Infection control, Internal medicine, Pneumonia, Dalbavancin and Osteomyelitis. Bacteremia and Tigecycline are some topics wherein Internal medicine research discussed in the most cited articles has an impact.
The journal focuses largely on the fields of Internal medicine, Retrospective cohort study, Coronavirus disease 2019 (COVID-19), Disease and Adverse effect. Internal medicine study tackled is connected to the field of Gastroenterology. The Retrospective cohort study studies discussed in the journal incorporate research from disciplines like
It facilitates discussions on Disease that incorporate concepts from other fields like Health care and Immunology, Vaccination. While Vaccination is the focus of Infectious Diseases and Therapy, it also provided insights into the studies of Epidemiology, Disease surveillance, Public health, Immunization and Pediatrics. The tackled Adverse effect research is interrelated with Clinical trial which concerns subjects like Pneumonia.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Infectious Diseases and Therapy (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Infectious Diseases and Therapy (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 6.01% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 29.07% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.05% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.02% of all publications and 41.86% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Francelise B. Cavassin;João Luiz Baú-Carneiro;Rogério R. Vilas-Boas;Flávio Queiroz-Telles
(2021)Unknown
(2022)Janet Y. Wu;Pavithra Srinivas;Jason M. Pogue
(2020)Marco Falcone;Giusy Tiseo;Beatrice Valoriani;Chiara Barbieri
(2021)Alex Soriano;Yehuda Carmeli;Ali S. Omrani;Luke S. P. Moore;Luke S. P. Moore
(2021)For those interested in expanding their medical career options, online nursing programs offer flexible pathways to advance. Many professionals start with a 6-month rn to bsn program, which allows registered nurses to earn their Bachelor of Science in Nursing quickly while continuing to work.
Further specialization is possible through programs like adn to np that bridge the gap between Associate Degree in Nursing and Nurse Practitioner qualifications. These programs are tailored for nurses aiming to take on more clinical responsibilities and leadership roles in healthcare.
Non-nurses looking to enter the nursing field can explore direct entry msn programs online. These accelerated options enable career changers to earn a Master of Science in Nursing without prior nursing licenses, opening doors to advanced practice roles.
Choosing the right school also impacts the learning experience and career outcome. Comparing institutions such as the wgu vs chamberlain vs capella compare online rn to bsn programs can help students make informed decisions based on curriculum, flexibility, and cost.
Overall, these diverse online degree options provide multiple routes to advance in healthcare, catering to a range of students—from current nurses seeking upward mobility to newcomers entering the profession.
